Skip to main content
The RheumNow faculty have been glued to their monitors all day, watching video, and running down abstract presentations to find the best – several of these stood out as #ACRBests. Here is a listing of “Best” they saw on Day 1.
Patients with axial spondyloarthritis (axSpA) often have increased absence from work as well as reduced productivity at work, which can have profound impacts for not only the affected individual and their families, but also lead to wider economic and social burden.
The ACR meeting is the premier educational event in rheumatology every year; it’s big for clinicians, academics, North American and international rheumatologists and those who will be presenting their research for the first time. Your objectives in attending the annual meeting are:
Lung Now: Drs. Pope and Sparks
RT @RichardPAConway: @rheum_cat presenting a really well designed study looking at association between TNFi use and inci

Richard Conway RichardPAConway

4 years 10 months ago
@rheum_cat presenting a really well designed study looking at association between TNFi use and incident hypertension in axSpA. No association found. Abstr#0910 #ACR21 @RheumNow https://t.co/w7o1oDreVL
RT @DrPetryna: Abst0569 #acr21 @RheumNow mortality in SpA:⬆️ overall mortality in AS (RR 1.64, 95% CI: 1.49-1.80,) b

Olga Petryna DrPetryna

4 years 10 months ago
Abst0569 #acr21 @RheumNow mortality in SpA:⬆️ overall mortality in AS (RR 1.64, 95% CI: 1.49-1.80,) but not PsA (RR: 1.12, 95% CI: 0.96-1.30). CV, resp & infection specific mortality significantly higher for PsA Cancer related mortality in PsA not higher than the gen pop
RT @ericdeinmd: #ACR21 Abs#0825
Early RA -Rx-naive: 48 wk, csDMARD+GC vs. 3 bDMARD+MTX (CZP/ABA/TCZ)
⭐️Superiority f

Eric Dein ericdeinmd

4 years 10 months ago
#ACR21 Abs#0825 Early RA -Rx-naive: 48 wk, csDMARD+GC vs. 3 bDMARD+MTX (CZP/ABA/TCZ) ⭐️Superiority for ABA+MTX and CZP+MTX vs. to csDMARD+GC, not in TCZ+MTX ⭐️ Radiographic progression low in all ▶️ Short study w very aggressive 1st line combo Rx https://t.co/TJPZkqmN8z @Rheumnow
RT @Yuz6Yusof: #ACR21 #Abstr0690 Great work by @didemsayginmd et al. 2016 ACR-EULAR Myositis Response Criteria concurred

Md Yuzaiful Md Yusof Yuz6Yusof

4 years 10 months ago
#ACR21 #Abstr0690 Great work by @didemsayginmd et al. 2016 ACR-EULAR Myositis Response Criteria concurred with patient-reported outcomes (muscle disease activity, strength, pain, fatigue, physical function, quality of life and physical activity) @RheumNow https://t.co/IV3mAXKhbt https://t.co/GWC6IDcJSm
RT @AkhilSoodMD: Abst 0562
Ungprasert & colleagues examine hospitalization and resource utilization among patients

Akhil Sood MD AkhilSoodMD

4 years 10 months ago
Abst 0562 Ungprasert & colleagues examine hospitalization and resource utilization among patients with #AnkylosingSpondylitis - Prevalence is high - Infection was among the most common reasons for hospitalization (sepsis, pneumonia, UTI) #ACR21 @RheumNow https://t.co/UftoFllE1v
RT @ericdeinmd: #ACR21 Abs#0828. SELECT-COMPARE UPA vs ADA for RA at 3 yrs
⭐️More pts stay on UPA vs ADA (47 vs 36%)

Eric Dein ericdeinmd

4 years 10 months ago
#ACR21 Abs#0828. SELECT-COMPARE UPA vs ADA for RA at 3 yrs ⭐️More pts stay on UPA vs ADA (47 vs 36%) ⭐️Adverse drug events similar between groups. UPA has ⬆️ zoster, lymphopenia, hepatic and CPK elevations https://t.co/eLCytSX7Gz @Rheumnow https://t.co/i8NjSgImVq
RT @AurelieRheumo: 🩸 Hb levels markers of RA activity and structural progression? Boston BRASS registry: 1500+ patien

Aurelie Najm AurelieRheumo

4 years 10 months ago
🩸 Hb levels markers of RA activity and structural progression? Boston BRASS registry: 1500+ patients. Low hb at headline associated w/ MTX TNFi and ⬆️ increase in TSS. Not that surprising provided low Hb is a marker of systemic inflammation. #Abtr0786 #ACR21 @Rheumnow https://t.co/eQLGxsANkk
RT @DrPetryna: Abst0907 #ACR21 @RheumNow observation of GLAS cohort of nrAxSpA pts over 6 yrs showed ~10% of pts progres

Olga Petryna DrPetryna

4 years 10 months ago
Abst0907 #ACR21 @RheumNow observation of GLAS cohort of nrAxSpA pts over 6 yrs showed ~10% of pts progress to AS every 2 years. Specifically after two, four and six years, 8/79 (10.1%), 4/48 (8.3%) and 3/24 (12.5%) nr-axSpA patients progressed to AS. https://t.co/hVpNz1kEgE
RT @KDAO2011: Can RA be cured?
Dr. Thomas' proof of concept RA immunotherapy study: DEN-181 is a liposome immunotherapy

TheDaoIndex KDAO2011

4 years 10 months ago
Can RA be cured? Dr. Thomas' proof of concept RA immunotherapy study: DEN-181 is a liposome immunotherapy given by SQ injx; it's presented by LN-DCs causing: CTL exhaustion while controlling autoreactive CD4+ T cells #ACRbest @rheumnow #ACR21 Abst#0967should have been a plenary! https://t.co/6ZzDgavafS
RT @DrMiniDey: Does #RA treatment affect low Hb levels? Is there a relationship between Hb and radiographic progression?

Mrinalini Dey DrMiniDey

4 years 10 months ago
Does #RA treatment affect low Hb levels? Is there a relationship between Hb and radiographic progression? #ACR21 Abs#0787 👉🏼Sustained improvements in Hb when treated with bio/non-bio DMARDs 👉🏼Low Hb assoc with incr radiographic progression @RheumNow https://t.co/DWgoiqYfAt https://t.co/aSRCT2vGjW
RT @swethaann23: Prospective multicenter Screening for Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Study e

swethaann23 swethaann23

4 years 10 months ago
Prospective multicenter Screening for Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Study evaluated 240 patients with axSpA ⭐️Imaging of the SIJ and spine DOES NOT differ in Ps axSpA or axSpA associated with iritis or colitis Abst# 0902 #ACR21 #ACRBest @RheumNow https://t.co/Y2bRlysXI5
×